Viemed Healthcare reports Q2 2023 record revenue of $43.3M, up 31% YoY

VIEMED HEALTHCARE, INC.

2023-Q2 EPS reported $0.10 revenue$82,867,000

Net revenues of $43.3M for Q2 2023, a new Company record, up 31% YoY; HMP acquisition contributed $2.5M.
Net income totaled $2.3M for the quarter ended June 30, 2023.
Adjusted EBITDA of $9.8M for Q2 2023, a 52% increase over Q2 2022.
Core net revenues (excluding HMP) grew approximately 9% sequentially from Q1 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

VIEMED HEALTHCARE, INC. reported three and six months ended June 30, 2023 results: revenue $43.3 million, net income $2.3 million.

Period: three and six months ended June 30, 2023
Revenue: $43.3 million
Net income: $2.3 million
Result: reported results

Exact text from the filing

highlights (all dollar amounts are USD): • Net revenues attributable to the Company's core business for the quarter ended June 30, 2023 reached a new Company record of $43.3 million, representing an increase of $10.2 million, or 31%, over core net revenues reported for the comparable quarter ended June 30, 2022. Net revenues for the quarter ended June 30,

View on SEC.gov

Browse all earnings releases →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-23-000110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.